Radnostix INIS
OTC INIS
$0.05 +0.01 (+25.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Radnostix (INIS) Gains from Sales and Divestitures (2011 - 2022)

Updated

Radnostix (INIS) recorded Gains from Sales and Divestitures of $13,492 in FY2024.

Analysis

Radnostix (INIS) Gains from Sales and Divestitures (2011 - 2022) Analysis & Trends

Starting with FY2010, Radnostix's Gains from Sales and Divestitures history includes 7 years.

  • Annual Gains from Sales and Divestitures has a five-year compound annual growth rate of 51.3% (FY2019 to FY2024).
  • The FY2024 figure is the lowest annual Gains from Sales and Divestitures since FY2019.
  • Per Business Quant data, INIS's Gains from Sales and Divestitures was $1.8 million in FY2022 and $36,000 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Radnostix 26.46 Mn 20.57 Mn 1.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 2,022.00
Mar 31, 2022 1.80 Mn
Dec 31, 2020 27,500.00
Dec 31, 2018 -44,195.00
Sep 30, 2013 276.00
Jun 30, 2013 36,419.00
Mar 31, 2013 3,607.00
Sep 30, 2011 -2,781.00
Mar 31, 2011 -3,145.00
API Access

Radnostix Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=INIS&period=max&api_key=YOUR_API_KEY